Docoh
Loading...

Wed. 17 Nov 2021, 6:43am ETBenzinga
In: News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers

  • 17 Education & Technology Group Inc. (NASDAQ:YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10 million buyback program.
  • Rockwell Medical, Inc. (NASDAQ:RMTI) rose 58.6% to $0.7632 in pre-market trading after the company announced results from a study demonstrated no drug-drug interaction between ferric pyrophosphate citrate and unfractionated heparin.
  • SPI Energy Co., Ltd. (NASDAQ:SPI) shares rose 20% to $7.38 in pre-market trading after gaining 9% on Tuesday.
  • Asia Pacific Wire & Cable Corporation Limited (NASDAQ:APWC) rose 19% to $3.19 in pre-market trading after the company posted a narrower loss for the first half of the year.
  • Progenity, Inc. (NASDAQ:PROG) rose 14.7% to $5.55 in pre-market trading. Progenity shares jumped over 39% on Tuesday amid continued retail investor interest on social media.
  • Mullen Automotive, Inc. (NASDAQ:MULN) rose 12.6% to $14.80 in pre-market trading after gaining 11% on Tuesday.
  • Canoo Inc. (NASDAQ:GOEV) rose 12.6% to $11.77 in pre-market trading. Canoo shares surged around 24% on Tuesday after the company said it will accelerate its advanced manufacturing production in the US to begin before Q4.
  • Lucid Group, Inc (NASDAQ:LCID) shares rose 11.1% to $61.82 in pre-market trading. Lucid Group shares jumped 24% on Tuesday after the company announced Q3 financial results.
  • Camber Energy, Inc. (NYSE:CEI) rose 10.8% to $1.23 in pre-market trading after gaining around 7% on Tuesday.
  • Bone Biologics Corporation (NASDAQ:BBLG) rose 10.6% to $4.28 in pre-market trading. Bone Biologics recently reported a Q3 loss of $0.17 per share.
  • Vir Biotechnology, Inc. (NASDAQ:VIR) shares rose 9.6% to $36.62 in pre-market trading. GlaxoSmithKline and Vir Biotechnology recently announced topline data from COMET-TAIL Phase 3 trial evaluating sotrovimab delivered via Intramuscular (IM) administration compared to IV administration in high-risk COVID-19 patients.
  • Chembio Diagnostics, Inc. (NASDAQ:CEMI) rose 8.3% to $2.23 in pre-market trading after the company announced the submission of an Emergency Use Authorization application to the FDA for the new DPP SARS-CoV-2 Antigen test.
  • Lion Group Holding Ltd. (NASDAQ:LGHL) rose 7.5% to $2.29 in pre-market trading after gaining 5% on Tuesday.
  • Innoviz Technologies Ltd. (NASDAQ:INVZ) rose 7.2% to $6.35 in pre-market trading. Innoviz Technologies, last week, reported a Q3 loss of $0.20 per share on sales of $2.10 million.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Cyclo Therapeutics, Inc. (NASDAQ:CYTH) fell 14.2% to $6.30 in pre-market trading after the company reported pricing of $11.7 million underwritten public offering of common stock.
  • Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) fell 12.7% to $9.92 in pre-market trading after Roche Holding AG terminated a partnership with the company to jointly develop a COVID-19 antiviral pill.
  • SOC Telemed, Inc. (NASDAQ:TLMD) shares fell 11.5% to $2.63 in pre-market trading. SOC Telemed, last week, reported better-than-expected Q3 EPS and sales results and raised FY21 guidance.
  • DLocal Limited (NASDAQ:DLO) shares fell 8.7% to $42.90 in pre-market trading after reporting downbeat quarterly earnings.
  • Creative Realities, Inc. (NASDAQ:CREX) fell 8.2% to $2.25 in pre-market trading. The company recently posted downbeat quarterly sales.
  • Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares fell 8.1% to $2.16 in pre-market trading. Altamira Therapeutics recently announced efficacy data from testing its Bentrio nasal spray in vitro against the Delta variant of the SARS-CoV-2 virus.
  • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) shares fell 8.1% to $2.51 in pre-market trading after jumping over 48% on Tuesday.
  • StoneCo Ltd. (NASDAQ:STNE) fell 7.9% to $29.16 in pre-market trading after the company reported Q3 results.
  • Second Sight Medical Products, Inc. (NASDAQ:EYES) fell 7.3% to $3.16 in pre-market trading after jumping 25% on Tuesday.
  • Verb Technology Company, Inc. (NASDAQ:VERB) shares fell 6.4% to $1.89 in pre-market trading after the company reported at the market equity offering program.
  • iQIYI, Inc. (NASDAQ:IQ) fell 5% to $8.16 in pre-market trading following Q3 results.